{"log_id": 8859401669282016352, "direction": 0, "words_result_num": 49, "words_result": [{"probability": {"variance": 0.03054, "average": 0.825758, "min": 0.418245}, "location": {"width": 845, "top": 197, "height": 36, "left": 229}, "words": "如枣在疗出规维液学毒基线细胞舞数数值证实,如中性粒细胞心150/儿或小板<75×103)或餐"}, {"probability": {"variance": 0.021906, "average": 0.911219, "min": 0.454393}, "location": {"width": 839, "top": 227, "height": 36, "left": 228}, "words": "在开始滑疗前(第1周期)出现骨髓抑制,下一期或第一周期的治疗应推迟:直到液学指标恢复到可接受的水平"}, {"probability": {"variance": 0.022602, "average": 0.909747, "min": 0.406615}, "location": {"width": 659, "top": 260, "height": 32, "left": 229}, "words": "在奥沙利铂治疗前其后每个周期前要进行含有自舞胞分类计数的全业细胞针数检查"}, {"probability": {"variance": 0.032035, "average": 0.854051, "min": 0.387023}, "location": {"width": 829, "top": 288, "height": 33, "left": 228}, "words": "应充分知患餐服用奥沙利镇5氟尿嘴后发生泻/吐、黏膜炎口腔炎及申性粒细胞减少等情况的危险性"}, {"probability": {"variance": 0.035509, "average": 0.890904, "min": 0.367833}, "location": {"width": 559, "top": 320, "height": 31, "left": 228}, "words": "与他们的医有密切接触以保一发生问题时能采取适当的措施处理之"}, {"probability": {"variance": 0.021366, "average": 0.913456, "min": 0.383589}, "location": {"width": 847, "top": 346, "height": 35, "left": 228}, "words": "如果发生膜炎/口腔炎,有不伴有申性粒细胞减少下次服药应推迟至膜炎口腔炎恢复到至少级:和或"}, {"probability": {"variance": 0.043886, "average": 0.840557, "min": 0.356279}, "location": {"width": 208, "top": 384, "height": 25, "left": 229}, "words": "中性救胞水平≥1.5×10/L"}, {"probability": {"variance": 0.045338, "average": 0.776379, "min": 0.37651}, "location": {"width": 846, "top": 407, "height": 31, "left": 230}, "words": "奥沙利铂与5(联会联鑫精酸(甲费氢意会用时,根据5氟尿罐璇相美的毒对基剂作相"}, {"probability": {"variance": 0.000117, "average": 0.985994, "min": 0.967591}, "location": {"width": 68, "top": 446, "height": 19, "left": 230}, "words": "应的调整"}, {"probability": {"variance": 0.030642, "average": 0.858745, "min": 0.350242}, "location": {"width": 840, "top": 465, "height": 31, "left": 235}, "words": "当出现严重/威生命(级)的腹、严重(3心级)的中性粒细胞减少症(中性胞<110儿L),严重(3n级)的小"}, {"probability": {"variance": 0.049625, "average": 0.820787, "min": 0.359803}, "location": {"width": 846, "top": 493, "height": 34, "left": 230}, "words": "板减症(血小板50X10儿必须警用巢沙利销至症状改善或消除,须将翼沙利铂临应翔剂量从"}, {"probability": {"variance": 0.039458, "average": 0.795325, "min": 0.388308}, "location": {"width": 764, "top": 523, "height": 32, "left": 230}, "words": "85mg/m降到65mg/m晚期肿化疗5mg精助疗),井且相应低5氟尿应用的潮量"}, {"probability": {"variance": 0.023827, "average": 0.867736, "min": 0.463129}, "location": {"width": 849, "top": 552, "height": 32, "left": 229}, "words": "如果有无法解样的吸系统症优发主,如痰性干咳、呼吸困难、肺泡罗有放射影像学依据的肺浸润,应"}, {"probability": {"variance": 0.040084, "average": 0.853517, "min": 0.382083}, "location": {"width": 562, "top": 583, "height": 30, "left": 228}, "words": "即停止应用该药直到一步肺都检查确定排除发生质性炎的可能为"}, {"probability": {"variance": 0.03711, "average": 0.846607, "min": 0.364504}, "location": {"width": 846, "top": 610, "height": 32, "left": 230}, "words": "如果不能确定肝功能检查结果异常静脉高症是由转移引起的,腹考虑奥沙利算引起的少见的肝租管"}, {"probability": {"variance": 6.6e-05, "average": 0.992266, "min": 0.977978}, "location": {"width": 103, "top": 648, "height": 22, "left": 230}, "words": "异常的可能"}, {"probability": {"variance": 0.017722, "average": 0.900557, "min": 0.670368}, "location": {"width": 73, "top": 678, "height": 23, "left": 194}, "words": "配催禁忌"}, {"probability": {"variance": 0.01811, "average": 0.900069, "min": 0.5036}, "location": {"width": 813, "top": 698, "height": 32, "left": 234}, "words": "不得与碱性药物或溶液(特别是5氟尿嘧啶,性溶液、氨丁三醇和含辅料丁三醇的叶酸类药品)混合使用"}, {"probability": {"variance": 0.00059, "average": 0.978351, "min": 0.920515}, "location": {"width": 177, "top": 734, "height": 24, "left": 234}, "words": "不要用盐溶液配制和稀"}, {"probability": {"variance": 0.010028, "average": 0.958947, "min": 0.370778}, "location": {"width": 763, "top": 757, "height": 31, "left": 235}, "words": "不要与其它任何药物混合或经同一个输液通道同使用(【用法用量】中“使用时的特殊注意事项”)"}, {"probability": {"variance": 1e-06, "average": 0.99898, "min": 0.997241}, "location": {"width": 189, "top": 792, "height": 24, "left": 233}, "words": "不要使用含铝的注射材料"}, {"probability": {"variance": 0.019906, "average": 0.932549, "min": 0.454637}, "location": {"width": 261, "top": 821, "height": 27, "left": 194}, "words": "对驾驶人员及操纵机械人员的影响"}, {"probability": {"variance": 0.021982, "average": 0.900684, "min": 0.410833}, "location": {"width": 849, "top": 844, "height": 32, "left": 230}, "words": "尚来对奥沙利铂对驾驶和操线机械的能力产生的效应进行研究:是,奥沙利铂治疗可以导致头、恶心和喉吐危"}, {"probability": {"variance": 0.017391, "average": 0.930563, "min": 0.360887}, "location": {"width": 847, "top": 874, "height": 32, "left": 195}, "words": "险性的培加,可以致能够影响步态平衡的神经系症状,这可能对驾驶和操机械的能力产生轻度或中度影"}, {"probability": {"variance": 0.026083, "average": 0.902071, "min": 0.366906}, "location": {"width": 844, "top": 904, "height": 30, "left": 230}, "words": "视觉异常:特别是短暂性视觉丧停止治疗可逆),以影咽想者驾驶和操纵机械的能力。因此,应该警告患"}, {"probability": {"variance": 0.016168, "average": 0.940251, "min": 0.473635}, "location": {"width": 396, "top": 938, "height": 27, "left": 195}, "words": "这些事件可能对驾驶或操纵机械的能力产主潜在效应"}, {"probability": {"variance": 0.001578, "average": 0.983227, "min": 0.858651}, "location": {"width": 198, "top": 970, "height": 23, "left": 202}, "words": "【孕妇及哺乳期妇女用药"}, {"probability": {"variance": 0.017026, "average": 0.939856, "min": 0.429211}, "location": {"width": 851, "top": 990, "height": 35, "left": 230}, "words": "迄今为止,尚无资料确定奥沙利在孕妇中使用的安全性根据临床前的经验,临推荐剂量的奥沙利铂可以致死"}, {"probability": {"variance": 0.029045, "average": 0.902421, "min": 0.359295}, "location": {"width": 882, "top": 1021, "height": 33, "left": 199}, "words": "和或致。因此,在孕中,不生张用沙利铂。只有在对胎儿的险性进行了充分的评价并征得子患的同意后,方"}, {"probability": {"variance": 0.007992, "average": 0.924363, "min": 0.723053}, "location": {"width": 152, "top": 1060, "height": 22, "left": 200}, "words": "可考虑使用奥沙利铂"}, {"probability": {"variance": 0.024145, "average": 0.901867, "min": 0.520681}, "location": {"width": 592, "top": 1081, "height": 32, "left": 233}, "words": "既往未曾研究过该药物是香会通过乳排泄。在使用奥沙利铂期间应当避免哺乳"}, {"probability": {"variance": 0.035106, "average": 0.899602, "min": 0.386125}, "location": {"width": 757, "top": 1109, "height": 33, "left": 235}, "words": "行其它细胞毒性药物一样:对育龄女患者而,在开始奥沙利铂化疗前,应该采取有效的避孕措施"}, {"probability": {"variance": 2.5e-05, "average": 0.99407, "min": 0.985448}, "location": {"width": 92, "top": 1148, "height": 21, "left": 203}, "words": "【儿童用药"}, {"probability": {"variance": 0.007542, "average": 0.953355, "min": 0.647917}, "location": {"width": 346, "top": 1172, "height": 29, "left": 231}, "words": "目前尚不确定本在儿童中应用的安全有效性"}, {"probability": {"variance": 0.000226, "average": 0.983977, "min": 0.964241}, "location": {"width": 92, "top": 1207, "height": 21, "left": 203}, "words": "【老年用药"}, {"probability": {"variance": 0.022886, "average": 0.917229, "min": 0.391903}, "location": {"width": 837, "top": 1228, "height": 33, "left": 231}, "words": "对于年龄超过65岁的患者,奥沙利铂作为单药或与5氟尿嘧联合应用,都求见急性毒性反的发生增加因此"}, {"probability": {"variance": 0.004206, "average": 0.95868, "min": 0.76894}, "location": {"width": 274, "top": 1265, "height": 25, "left": 200}, "words": "对于老年患者,没有特殊的剂量调整"}, {"probability": {"variance": 0.010934, "average": 0.94718, "min": 0.69323}, "location": {"width": 126, "top": 1296, "height": 22, "left": 204}, "words": "【药物相互作用"}, {"probability": {"variance": 0.010598, "average": 0.952748, "min": 0.443313}, "location": {"width": 849, "top": 1317, "height": 31, "left": 233}, "words": "在每两周给药的患者中规察到85mg/m2奥沙利铂和注氟尿嘧啶之间没有药代动力学相互作用,但在每3周给予"}, {"probability": {"variance": 0.010501, "average": 0.952762, "min": 0.576957}, "location": {"width": 881, "top": 1346, "height": 33, "left": 202}, "words": "30mg/m2奥沙利铂剂量的患者中观案到氯尿嘧的血浆水平约增加20%体外试验中,下列这些药物不能取代血浆"}, {"probability": {"variance": 0.013139, "average": 0.928266, "min": 0.522791}, "location": {"width": 882, "top": 1376, "height": 32, "left": 200}, "words": "蛋白上的铂:红素、水杨酸盐、丙戊酸钠、格拉琼和紫杉醇。在体外研究中,奥沙利铂既不被细胞色素P450同工酶"}, {"probability": {"variance": 0.022397, "average": 0.907013, "min": 0.418309}, "location": {"width": 878, "top": 1405, "height": 33, "left": 201}, "words": "代谢,也不抑制细胞色素P450同工的,因此预让雀患者林内不会有P450介导的药物间互作用。由于含铂品种主要"}, {"probability": {"variance": 0.021692, "average": 0.934775, "min": 0.359878}, "location": {"width": 784, "top": 1436, "height": 31, "left": 200}, "words": "通过肾脏消除,还未进行特定的研究,但是音用有潜在肾脏毒性的化合物可能会降低这些产品的清除率"}, {"probability": {"variance": 5.9e-05, "average": 0.995609, "min": 0.978475}, "location": {"width": 93, "top": 1474, "height": 21, "left": 203}, "words": "【药物过量】"}, {"probability": {"variance": 0.008657, "average": 0.953115, "min": 0.561006}, "location": {"width": 841, "top": 1495, "height": 33, "left": 238}, "words": "没有已知用于治疗奥沙利铂过量的解毒剂。除血小板减少外,过量使用奥沙利铂的预期并发症包括超敏反应、骨髓"}, {"probability": {"variance": 0.007343, "average": 0.959979, "min": 0.524934}, "location": {"width": 862, "top": 1526, "height": 31, "left": 199}, "words": "抑制、恶心,呕吐、腹泻和神经毒桂目前已有几例有关过量使用奥沙利铂的病例报告。其中观察到的不良反应为"}, {"probability": {"variance": 0.010933, "average": 0.95386, "min": 0.643748}, "location": {"width": 143, "top": 1565, "height": 21, "left": 200}, "words": "级血小板减少(<25"}, {"probability": {"variance": 0.030597, "average": 0.893905, "min": 0.413833}, "location": {"width": 672, "top": 1557, "height": 27, "left": 410}, "words": "3)不伴出血、贫血、感觉神经变(如感觉异常、感觉迟钝、瞻挛和面部肌肉痉挛)、"}, {"probability": {"variance": 0.034454, "average": 0.883449, "min": 0.370238}, "location": {"width": 882, "top": 1585, "height": 32, "left": 200}, "words": "肠系统疾病(如恶心吐、口腔炎、胃气眼、腹胀和1级肠梗阻)、级瘾水、呼吸困难、哮鸣、搁部疼痛、呼吸"}], "language": 3}